Skip to content

Advertisement

  • Protocol
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

  • 1, 2,
  • 3, 4Email author,
  • 17,
  • 1, 5,
  • 1,
  • 6,
  • 7,
  • 8,
  • 9,
  • 10, 11, 12,
  • 13,
  • 8,
  • 2, 14 and
  • 1, 2, 8, 13, 15, 16
Systematic Reviews20176:120

https://doi.org/10.1186/s13643-017-0517-4

Received: 1 September 2016

Accepted: 9 June 2017

Published: 26 June 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 Sep 2016 Submitted Original manuscript
24 Mar 2017 Reviewed Reviewer Report - Andrew Webster
12 May 2017 Author responded Author comments - David Pettitt
Resubmission - Version 2
12 May 2017 Submitted Manuscript version 2
Publishing
9 Jun 2017 Editorially accepted
26 Jun 2017 Article published 10.1186/s13643-017-0517-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
The Oxford – UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK
(2)
Department of Paediatrics, University of Oxford, Oxford, UK
(3)
University of St. Andrews School of Medicine, University of St. Andrews, St. Andrews, UK
(4)
, Glenrothes, UK
(5)
Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
(6)
Flagship Ventures, Cambridge, USA
(7)
Sartorius Stedim, Göttingen, Germany
(8)
Said Business School, University of Oxford, Oxford, UK
(9)
Division of Cell Transplantation and Regenerative Medicine, University of Stanford, Stanford, USA
(10)
Harvard Medical School, Harvard University, Boston, USA
(11)
Brigham and Women’s Hospital, Boston, USA
(12)
Harvard-MIT Division of Health Sciences and Technology, Cambridge, USA
(13)
Harvard Stem Cell Institute, Cambridge, USA
(14)
Department of Biomedicine, University of Basel and Basel University Children’s Hospital, Basel, Switzerland
(15)
Centre for Behavioral Medicine, UCL School of Pharmacy, University College London, London, UK
(16)
USCF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI), Stanford, USA
(17)
Orthopedic Surgery Departement, University of Cambridge, Cambridge, UK

Advertisement